The EPO published B. Braun Melsungen AG's European patent application EP4366796A1 for a single-use medical item incorporating an integrated marker. The application claims priority to IPC classifications A61M 5/14, A61M 39/08, and A61M 39/28, indicating technical innovations in medical markers and catheter/line management. The filing names five inventors and designates all European extension states including AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, and TR.

This publication is informational regarding patent rights and does not impose compliance obligations on healthcare providers or medical device manufacturers. Parties interested in the technology or potential licensing should monitor the EPO register for examination results and potential opposition periods. Competitors developing similar single-use medical marker technology should conduct freedom-to-operate analyses.